These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


116 related items for PubMed ID: 2416196

  • 1. Synthetic hepatitis B surface antigen peptide vaccine.
    Dreesman GR, Sparrow JT, Frenchick PJ, Kennedy RC.
    Adv Exp Med Biol; 1985; 185():129-37. PubMed ID: 2416196
    [Abstract] [Full Text] [Related]

  • 2. Antigen mimicry by anti-idiotype antibodies that recognize a common anti-hepatitis B surface antigen idiotype.
    Kennedy RC, Dreesman GR.
    Adv Exp Med Biol; 1985; 185():139-47. PubMed ID: 2416197
    [Abstract] [Full Text] [Related]

  • 3. Epitopes associated with a synthetic hepatitis B surface antigen peptide.
    Ionescu-Matiu I, Kennedy RC, Sparrow JT, Culwell AR, Sanchez Y, Melnick JL, Dreesman GR.
    J Immunol; 1983 Apr; 130(4):1947-52. PubMed ID: 6187828
    [Abstract] [Full Text] [Related]

  • 4. Immunogenicity of conjugates and micelles of synthetic hepatitis B surface antigen peptides.
    Sanchez Y, Ionescu-Matiu II, Sparrow JT, Melnick JL, Dreesman GR.
    Intervirology; 1982 Apr; 18(4):209-13. PubMed ID: 6183231
    [Abstract] [Full Text] [Related]

  • 5. Immunity to hepatitis B: analysis of antibody and cellular responses in recipients of a plasma-derived vaccine using synthetic peptides mimicking S and pre-S regions.
    Steward MW, Sisley BM, Stanley C, Brown SE, Howard CR.
    Clin Exp Immunol; 1988 Jan; 71(1):19-25. PubMed ID: 3349646
    [Abstract] [Full Text] [Related]

  • 6. Enhancement of viral hepatitis B antibody (Anti-HBs) response to a synthetic cyclic peptide by priming with anti-idiotype antibodies.
    Kennedy RC, Sparrow JT, Sanchez Y, Melnick JL, Dreesman GR.
    Virology; 1984 Jul 15; 136(1):247-52. PubMed ID: 6610985
    [Abstract] [Full Text] [Related]

  • 7. Lack of genetic restriction by a potential anti-idiotype vaccine for type B viral hepatitis.
    Kennedy RC, Eichberg JW, Dreesman GR.
    Virology; 1986 Jan 30; 148(2):369-74. PubMed ID: 3484564
    [Abstract] [Full Text] [Related]

  • 8. Antibodies to hepatitis B surface antigen (HBsAg) elicited by immunization with a synthetic peptide covalently linked to liposomes.
    Neurath AR, Kent SB, Strick N.
    J Gen Virol; 1984 May 30; 65 ( Pt 5)():1009-14. PubMed ID: 6202827
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of a common human anti-hepatitis B surface antigen idiotype by a cyclic synthetic peptide.
    Kennedy RC, Dreesman GR, Sparrow JT, Culwell AR, Sanchez Y, Ionescu-Matiu I, Hollinger FB, Melnick JL.
    J Virol; 1983 May 30; 46(2):653-5. PubMed ID: 6188865
    [Abstract] [Full Text] [Related]

  • 10. Mutated epitopes of hepatitis B surface antigen fused to the core antigen of the virus induce antibodies that react with the native surface antigen.
    Shiau AL, Murray K.
    J Med Virol; 1997 Mar 30; 51(3):159-66. PubMed ID: 9139078
    [Abstract] [Full Text] [Related]

  • 11. Immunoreactivity of HCV/HBV epitopes displayed in an epitope-presenting system.
    Chen Y, Xiong X, Liu X, Li J, Wen Y, Chen Y, Dai Q, Cao Z, Yu W.
    Mol Immunol; 2006 Feb 30; 43(5):436-42. PubMed ID: 16337486
    [Abstract] [Full Text] [Related]

  • 12. Subunit, recombinant and synthetic hepatitis B vaccines.
    Zuckerman AJ.
    Scand J Gastroenterol Suppl; 1985 Feb 30; 117():27-38. PubMed ID: 3912963
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Immunological evaluation of three generations of anti-idiotype vaccine: study of B and T cell responses following priming with anti-idiotype, anti-idiotype peptide and its MAP structure.
    Rajadhyaksha M, Yang YF, Thanavala YM.
    Vaccine; 1995 Feb 30; 13(15):1421-6. PubMed ID: 8578819
    [Abstract] [Full Text] [Related]

  • 15. New broadly reactive neutralizing antibodies against hepatitis B virus surface antigen.
    Kucinskaite-Kodze I, Pleckaityte M, Bremer CM, Seiz PL, Zilnyte M, Bulavaite A, Mickiene G, Zvirblis G, Sasnauskas K, Glebe D, Zvirbliene A.
    Virus Res; 2016 Jan 04; 211():209-21. PubMed ID: 26541316
    [Abstract] [Full Text] [Related]

  • 16. Immunogenicity in chimpanzees of experimental hepatitis B vaccines prepared from intact hepatitis B virus, purified polypeptides, or polypeptide micelles.
    Tabor E, Howard CR, Skelly J, Snoy P, Goudeau A, Zuckerman AJ, Gerety RJ.
    J Med Virol; 1982 Jan 04; 10(1):65-74. PubMed ID: 7130967
    [Abstract] [Full Text] [Related]

  • 17. [Immunologic study of a synthetic peptide with HBsAg activity].
    Luo KX.
    Zhonghua Yi Xue Za Zhi; 1989 Jan 04; 69(1):28-30, 4. PubMed ID: 2474363
    [Abstract] [Full Text] [Related]

  • 18. Analysis of the antigenic epitopes of hepatitis B surface antigen involved in the induction of a protective antibody response.
    Waters JA, Brown SE, Steward MW, Howard CR, Thomas HC.
    Virus Res; 1992 Jan 04; 22(1):1-12. PubMed ID: 1371369
    [Abstract] [Full Text] [Related]

  • 19. Hepatitis B virus vaccine: identification of HBsAg/a and HBsAg/d but not HBsAg/y subtype antigenic determinants on a synthetic immunogenic peptide.
    Prince AM, Ikram H, Hopp TP.
    Proc Natl Acad Sci U S A; 1982 Jan 04; 79(2):579-82. PubMed ID: 6176997
    [Abstract] [Full Text] [Related]

  • 20. Immune response to synthetic peptide analogues of hepatitis B surface antigen specific for the a determinant.
    Bhatnagar PK, Papas E, Blum HE, Milich DR, Nitecki D, Karels MJ, Vyas GN.
    Proc Natl Acad Sci U S A; 1982 Jul 04; 79(14):4400-4. PubMed ID: 6181506
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.